MYELODYSPLASTIC SYNDROMES (MDS)
Clinical trials for MYELODYSPLASTIC SYNDROMES (MDS) explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROMES (MDS) trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROMES (MDS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough blood cancers: modified transplant aims to beat disease
Disease control OngoingThis study is for children and young adults (up to age 21) with high-risk blood cancers like leukemia and lymphoma. It tests a modified blood cell transplant from a partially matched family donor. The donor cells are processed in a lab to remove certain immune cells that can caus…
Matched conditions: MYELODYSPLASTIC SYNDROMES (MDS)
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Apr 02, 2026 00:41 UTC
-
Personalized drug approach aims to make cancer transplants safer
Disease control OngoingThis study is testing if adjusting the dose of a drug called rabbit ATG based on a patient's individual needs can help the immune system recover faster after a stem cell transplant. The goal is to reduce serious side effects and improve survival for children and adults with certa…
Matched conditions: MYELODYSPLASTIC SYNDROMES (MDS)
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC